Abstract
Several international and national consensus guidelines from professional bodies and expert panels are available for the management of breast cancers. The widely used international guidelines are from the National Comprehensive Cancer Network (NCCN), St. Gallen International Expert Consensus, and the European Society of Medical Oncology (ESMO) and the National Institute for Health and Care Excellence (NICE) of the UK. This article is an update from the Association of Breast Surgeons of India (ABSI) regarding the guidelines to manage breast cancer in India. The earlier version of the same was published in 2016. This article has been updated with the latest research work in the management of breast cancer to date and necessary changes made to the earlier version.
Similar content being viewed by others
References
Wild CP, Weiderpass E, Stewart BW, editors (2020) World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. Available from: http://publications.iarc.fr/586
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
WHO newsletter on breast cancer 26th March 2021; https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Accessed 3 July 2021
Arthur R, Wang Y, Ye K et al (2017) Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease. Breast Cancer Res Treat 165(3):623–631. https://doi.org/10.1007/s10549-017-4347-9
Jemal A, Bray F, Melissa MC, Jacques F, Elizabeth W, Forman D (2011) Global Cancer Statistics. CA Cancer J Clin 61:69–90
Report of National Cancer Registry Programme (ICMR-NCDIR), Bengaluru, India 2020. https://www.ncdirindia.org/All_Reports/Report_2020/default.aspx. Accessed 3 July 2021
Hassan Ali S, Somashekhar SP, Arun Kumar N (2019) Rate of breast-conserving surgery vs mastectomy in breast cancer: a tertiary care centre experience from South India. Indian J Surg Oncol 10:72–76. https://doi.org/10.1007/s13193-018-0818-7
Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS, ICMR-NCDIR-NCRP Investigator Group. Cancer Statistics (2020) 2020: Report from National Cancer Registry Programme, India. JCO Glob Oncol 6:1063–1075. https://doi.org/10.1200/GO.20.00122
Malvia S, Bagadi SA, Dubey US, Saxena S (2017) Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol 13(4):289–295. https://doi.org/10.1111/ajco.12661
Doval DC, Radhakrishna S, Tripathi R et al (2020) A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery. Sci Rep 10:5886. https://doi.org/10.1038/s41598-020-62618-3
Somashekhar SP, Agarwal G, Deo SVS, Chintamani, Raghu Ram P, Sarkar D, Parmar V (2017) Indian solutions for Indian problems-Association of Breast Surgeons of India (ABSI) practical consensus statement, recommendations, and guidelines for the treatment of breast cancer in India. Indian J Surg. 79(4):275–285. https://doi.org/10.1007/s12262-017-1666-3
Balic M, Thomssen C, Würstlein R, Gnant M, Harbeck N (2019) St. Gallen/Vienna 2019: A brief summary of the consensus discussion on the optimal primary breast cancer treatment. Breast Care 14:103–110. https://doi.org/10.1159/000499931
Somsekhar SP, Geeta K, Jain R, Nayyer R, Halder S, Malik VK et al (2018) Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer. South Asian J Cancer 7:79–82
Dey S (2014) Preventing breast cancer in LMICs via screening and/ or early detection: the real and the surreal. World J Clin Oncol 5(3):509–519
Pillarisetti RR (2021) United Kingdom to India—a “living bridge”: celebrating 25 positively eventful years (1996–2021). Indian J Surg . https://doi.org/10.1007/s12262-021-02806-1
Pillarisetti Raghu Ram (2020) “Perspective from India: improving breast health care” (Chapter 35) – “Breast Cancer: Global Quality Care”, edited by Didier Verhoeven, Cary Kaufman, Robert Mansel, Sabine Siesling. Oxford University Press, Oxford, pp 371–376
Tabar L, Fagerberg CJ, Gad A et al (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829–832 results in 549,091 women. Cancer 126:2971–2979
Duffy SW, Smith RA, Tabár L, Dean PB, Chen TH (2019) The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer 125(4):515–523
Duffy SW, LászlóTabár, Yen AM-F, Peter B, Dean M et al (2020) Mammography screening reduces rates of advanced and fatal breast cancers. Cancer 126(13):2971–2979. https://doi.org/10.1002/cncr.32859
Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 368:2053–2060
Harford JB (2011) Breast-cancer early detection in low-income and middle income countries: do what you can versus one size fits all. Lancet Oncol 12:306–312
Somashekhar SP, Kumar CR, Ashwin KR, Zaveri SS, Jampani A, Ramya Y, Parameswaran R, Rakshit S (2020) Can low-cost indo cyanine green florescence technique for sentinel lymph node biopsy replace dual dye (radio-colloid and blue dye) technique in early breast cancer: a prospective two-arm comparative study. Clin Breast Cancer 20(5):e576–e583. https://doi.org/10.1016/j.clbc.2020.03.013
Chauhan A, Sharma MM (2016) Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery. Med J Armed Forces India 72(1):12–18
Deo SV, Samaiya A, Shukla NK, Mohanti BK, Raina V, Purkayastha J, Bhutani M, Kar M, Hazarika S, Rath GK (2005) Breast conservation therapy for breast cancer: patient profile and treatment outcome at a tertiary care cancer centre. Natl Med J India 18(4):178–81
Vijaykumar DK, Arunlal M (2015) Management of axilla in 2015 in Indian scenario. Indian J Surg Oncol 6(4):435–439
Rolph R, Mehta S, Farhadi J (2016) Breast reconstruction: options post-mastectomy. Br J Hosp Med (Lond) 77(6):334–342
Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660
Malhotra H, Kowtal P, Mehra N, Pramank R, Sarin R, Rajkumar T, Gupta S, Bapna A, Bhattacharyya GS, Gupta S, Maheshwari A, Mannan AU, Reddy Kundur R, Sekhon R, Singhal M, Smruti BK, Sp S, Suryavanshi M, Verma A (2020) Genetic counseling, testing, and management of HBOC in India: an expert consensus document from Indian Society of Medical and Pediatric Oncology. JCO Glob Oncol 6:991–1008. https://doi.org/10.1200/JGO.19.00381
Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84
Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975
Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062
Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164
Kadri MSN, Patel KM, Bhargava PA, Shah FD, Badgujar NV, Tarapara BV, Patel PS, Shaikh MI, Shah K, Patel A, Pandya S, Vora H, Joshi CG, Joshi MN (2021) Mutational landscape for Indian hereditary breast and ovarian cancer cohort suggests need for identifying population specific genes and biomarkers for screening. Front Oncol 21(10):568786. https://doi.org/10.3389/fonc.2020.568786
Anampa J, Makower D, Sparano JA (2015) Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Med 17(13):195. https://doi.org/10.1186/s12916-015-0439-8
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99. https://doi.org/10.3322/caac.21388
Bhattacharyya GS, Doval DC, Desai CJ, Chaturvedi H, Sharma S, Somashekhar SP (2020) Overview of breast cancer and implications of overtreatment of early-stage breast cancer: an Indian perspective. JCO Glob Oncol 6:789–798. https://doi.org/10.1200/GO.20.00033
Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451–1467
Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388
Chew HK (2001) Adjuvant therapy for breast cancer: who should get what? West J Med 174(4):284–287
Sariego J, Zrada S, Byrd M et al (1995) Breast cancer in young patients. Am J Surg 170(3):243–245
Sariego J (2010) Breast cancer in the young patient. Am Surg 76(12):1397–1400
Meneses K, Holland AC (2014) Current evidence supporting fertility and pregnancy among young survivors of breast cancer. J Obstet Gynecol Neonatal Nurs. 43(3):374–81. https://doi.org/10.1111/1552-6909.12301
ter Welle-Butalid ME, Vriens IJH, Derhaag JG et al (2019) Counseling young women with early breast cancer on fertility preservation. J Assist Reprod Genet 36:2593–2604. https://doi.org/10.1007/s10815-019-01615-6
Acknowledgements
The authors would like to acknowledge the manuscript writing assistance provided by Dr. Manjusha Rajarshi, Mumbai.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Somashekhar, S.P., Deo, S.V.S., Sarkar, D. et al. Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India 2021—Indian Solutions for Indian Problems. Indian J Surg 84 (Suppl 3), 573–584 (2022). https://doi.org/10.1007/s12262-021-03160-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-021-03160-y